Investment Commentary – Q3 2020

Investment Commentary

n July, markets were buoyed overall by news of successful phase one trials for a COVID-19 vaccine. There were, however, signs of the virus re-emerging across developed markets, with a serious pick-up in cases and deaths in the US and a more modest up-tick in cases in the UK and mainland Europe